The primary aim of the lab is to advance mass spectrometry-based analysis of small molecules and metabolites, integrating lipidomics and metabolomics with quantitative and semi-quantitative mass spectrometry analyses, in various in vivo, ex vivo This approach aims to deepen our understanding of lipid pathways involved in cardiometabolic diseases, with a specific focus on sphingolipid metabolism.
Elin Chorell
Umeå University
Key Publications
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study—differences and similarities
Cardiovascular Research, 2025
Midlife Mediterranean diet is associated with subclinical carotid atherosclerosis in late midlife
European Journal of Preventive Cardiology, 2025
CETP inhibition Reduces Cardiovascular Events by Lowering of Cumulative LDL Exposure: Reconciling Evidence from Human Genetics and Clinical Trials
2024
Myofiber-specific lipidomics unveil differential contributions to insulin sensitivity in individuals of African and European ancestry
Heliyon, 2024
Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk
European Heart Journal Open, 2024